Skip to main content
Clinical Trials/CTRI/2014/11/005223
CTRI/2014/11/005223
Completed
Phase 4

ROLE OF ANTI-OXIDANTS ON OXIDATIVE STRESS INDEX IN THE PATIENTS OF VITILIGO

Shri Ram Murti Smarak Institute of Medical Sciences Bareilly0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L80- VitiligoHealth Condition 2: null- Vitiligo vulgaris
Sponsor
Shri Ram Murti Smarak Institute of Medical Sciences Bareilly
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Shri Ram Murti Smarak Institute of Medical Sciences Bareilly

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed case of vitiligo vulgaris
  • They are not under a therapeutic regimen for previous two months and had not received drugs containing any anti\-oxidants
  • Patient having VIDA score \>\= \+1
  • Age \>\= 18 years
  • Patients should be willing for Investigation, Treatment and Regular Follow up

Exclusion Criteria

  • Age \< 18 years
  • Pregnancy or Lactation at present
  • Hepatic, Renal, Lipid Profile Abnormalities
  • Past/Present history of any type of Malignancy
  • Patient unsure about attending treatment Schedule Regularly
  • Previous H/o any Hypersensitivity Reaction to anti\-oxidants
  • Patients who fail to come for follow up after Initiation of therapy
  • Patients with previous H/o Immunobullous disorders nad autoimmune diseases
  • Patient is an alcoholic and smoker

Outcomes

Primary Outcomes

Not specified

Similar Trials